Pandorum Technologies secures US$18 million in Series B funding to expand regenerative therapy programs MM Desk 11 February, 2026 Pandorum Technologies, a biotechnology company with operations in India and the United States, has raised Read More
Pandorum Technologies and Nucelion Therapeutics Partner to Manufacture Exosome-Based Therapies MM Desk 7 January, 2026 Pandorum Technologies, a clinical-stage regenerative medicine company developing programmable tissue regeneration platforms, has announced a Read More